Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

類似資料

• Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
  著者:: Horinouchi, Tomoko, 等
  出版事項: (2018)
• Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
  著者:: Nagano, China, 等
  出版事項: (2019)
• A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
  著者:: Yoshikawa, Norishige, 等
  出版事項: (2015)
• Rituximab for nephrotic syndrome in children
  著者:: Iijima, Kazumoto, 等
  出版事項: (2016)
• Rituximab Treatment for Nephrotic Syndrome in Children
  著者:: Iijima, Kazumoto, 等
  出版事項: (2014)